Quarterly report · Q2
3750.TEDINET S100PLQ1
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥1.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥668m | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | −¥381m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | −¥259m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | −¥437m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥418m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥237m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥539m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥47m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥561m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥78m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥34m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥561m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | −¥34m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥14.2bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥16.0bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥16.0bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.1bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥12.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.2bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.7bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥861m | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥852m | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥561m | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥702m | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥20m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥188m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥98m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥94m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥216m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥49m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥67m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥36m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥88m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-62.86 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-30.66 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.79 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.9 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.73 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 20.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.4% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | −¥74m |
| jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥84m |
| jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥84m |
| jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥119m |
| jpcrp040300-q2r_E05443-000Real Asset Managementreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E05443-000Real Asset Managementreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E05443-000Real Asset Managementreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥188m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | −¥307m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | −¥76m |
| jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥101m |
| jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥101m |
| jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥106m |
| jpcrp040300-q2r_E05443-000Real Asset Managementreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥568m |
| jpcrp040300-q2r_E05443-000Real Asset Managementreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥568m |
| jpcrp040300-q2r_E05443-000Real Asset Managementreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥78m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥668m |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥668m |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | −¥184m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 449
| Item | Context | Value | Unit |
|---|---|---|---|
| Decrease in cash and cash equivalents resulting from exclusion of subsidiaries from consolidation cce | Prior1YTDDuration | － | JPY |
| Decrease in cash and cash equivalents resulting from exclusion of subsidiaries from consolidation cce | CurrentYTDDuration | -150000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 1107927000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 560857000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember | 100683000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember | 567784000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 668468000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 668468000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember | 100683000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember | 567784000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 668468000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Net sales | Prior1YTDDuration | 668468000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember | -105935000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember | -77658000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | -183594000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -75779000 | JPY |
| Operating income | Prior1YTDDuration | -259373000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember | 83682000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember | 1089062000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 1172744000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 1172744000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember | 83682000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember | 1089062000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 1172744000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Net sales | CurrentYTDDuration | 1172744000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember | -118757000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember | -187918000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | -306675000 | JPY |
| Operating income | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -74309000 | JPY |
| Operating income | CurrentYTDDuration | -380985000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-11-11 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第19期第２四半期（自 2022年７月１日 至 2022年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社サイトリ細胞研究所（旧会社名 ＦＲＡＣＴＡＬＥ株式会社） |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |